Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
Loading
Revenue PerformanceStable
Percentile Rank64
3Y CAGR+610.3%
5Y CAGR+15.7%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+610.3%/yr
vs -78.3%/yr prior
5Y CAGR
+15.7%/yr
Recent acceleration
Acceleration
+688.6pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
3 yr
Consecutive growthStable
PeriodValueYoY Change
2025$49.80M+60.2%
2024$31.08M+2481.5%
2023$1.20M+766.2%
2022$139000.00-53.4%
2021$298000.00-98.8%
2020$24.00M-92.5%
2019$322.07M+409.5%
2018$63.21M-30.0%
2017$90.33M+8.4%
2016$83.34M-